ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Roche: FTC Requests More Information On Illumina Offer

DOW JONES NEWSWIRES U.S. regulators have asked Roche Holding AG (ROG.VX, RHHBY) for additional information about its proposed takeover of Illumina Inc. (ILMN), the drug maker said Tuesday. The Federal Trade Commission's request reflects antitrust concerns about Roche's microarray business and would delay any acquisition another 10 days after Roche complies with the second request under U.S. law. Roche is still working to complete its hostile takeover of Illumina, which continues to oppose the Swiss company's offer as inadequate. Illumina makes machines that use blood or tissue samples to decode a person's entire genetic makeup in about a week--a process known as DNA sequencing. Shares of the takeover target closed at $50.34 Tuesday and were unchanged after hours. Roche's cash offer values the company at $44.50 a share. -By Drew FitzGerald, Dow Jones Newswires; 212-416-2909; Andrew.FitzGerald@dowjones.com

Stock News for Illumina (ILMN)
DateTimeHeadline
02/03/201610:17:53Amended Statement of Ownership (sc 13g/a)
02/02/201618:40:00Illumina Posts 32% Decline in Profit
02/02/201616:36:32Current Report Filing (8-k)
02/02/201616:32:00Illumina Reports Financial Results for Fourth Quarter and Fiscal...
02/01/201616:42:40Current Report Filing (8-k)
02/01/201606:30:00Illumina Signs Multiple Biobank Deals
01/28/201618:11:12Statement of Changes in Beneficial Ownership (4)
01/28/201608:31:59Current Report Filing (8-k)
01/28/201606:30:00Illumina Appoints Dr. Frances Arnold to Its Board of Directors
01/21/201618:34:29Statement of Changes in Beneficial Ownership (4)
01/19/201606:30:00Illumina to Announce Fourth Quarter and Fiscal Year 2015 Financial...
01/14/201618:03:35Statement of Changes in Beneficial Ownership (4)
01/14/201612:04:17Current Report Filing (8-k)
01/11/201614:31:00Bio-Rad and Illumina to Co-Develop Comprehensive Solution for...
01/11/201614:29:00Illumina Extends Genomics Portfolio
01/10/201621:20:00Illumina Launches Firm to Pursue Gene-Based Cancer Blood Test
01/10/201617:29:00Illumina Forms New Company to Enable Early Cancer Detection via...
01/08/201616:05:00Illumina to Host Investor Call on Sunday, January 10, 2016
01/08/201608:32:00Illumina Files Patent Suit Against Premaitha's Customer in Poland
01/07/201616:05:00Illumina Files Two Patent Infringement Suits in Europe for Infringement...

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad